Skip to main content
SpringerLink
Log in

Severity of AD increases resource use and costs in France

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2010 euros

Reference

  • Rapp T, et al. Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study. Value in Health : 11 Nov 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.09.019

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Severity of AD increases resource use and costs in France. PharmacoEcon Outcomes News 792, 27 (2017). https://doi.org/10.1007/s40274-017-4550-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4550-2

Search

Navigation